Breast Cancer Home > Halaven
Halaven is prescribed to treat breast cancer in people who have late-stage cancer that has not responded adequately to other chemotherapy treatments. It is administered intravenously (by IV) over a short period of time. It works by preventing cell division and killing the cancer cells. Potential side effects include hair loss, fatigue, and nerve problems.
What Is Halaven?
Halaven™ (eribulin mesylate) is a chemotherapy medication approved for the treatment of breast cancer. It is licensed to treat late-stage cancer that has not responded to certain other chemotherapy regimens.(Click Halaven Uses for more information, including possible off-label uses.)
How Does Halaven Work?
Halaven is part of a group of medications called microtubule inhibitors. It works by preventing cell division and, eventually, causing the cell to die.While Halaven can kill both healthy and cancerous cells, it has a greater effect on cells that are multiplying rapidly. Generally, cancer cells multiply more rapidly than healthy cells and are, therefore, more affected by Halaven.